BioSpace News Archive

Expects to Complete Enrollment and Report Top-Line Data of the Phase 2b/3 PRISM Trial in Second Half of 2021 Cash Position Expected to Fund Operations into the Second Quarter of 2022

Full Year Revenue Increase of 15% Management to Host Conference Call Today at 5:00 pm ET

All nine patients with acute respiratory failure due to COVID-19 discharged from hospital within days after 3 rd COVI-MSC infusion Preparations are ongoing for initiating Phase 2 placebo-controlled study

- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Stifel 3 rd Annual CNS Day at 12:30 p.m. Eastern Time on Thursday Apr. 1, 2021. Eiry Roberts, Chief Medical Officer, and Kyle Gano , Chief Business Development and Strategy Officer, will present at the conference.

Mr. Lucier’s commitment to disruptive technology and global scale accelerated Company growth to more than $1 billion in net sales

The Accreditation Council for Medical Affairs (ACMA) conducted a congressional briefing on Wednesday, March 24 to discuss the important and growing role pharmaceutical Medical Affairs and Medical Science Liaison (MSL) professional

Record quarterly results highlighted by revenue of $27.1 million and pre-tax income of $15.8 million

Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today reported financial results for the fourth quarter and year ended December 31, 2020. This press release presents historical results, for the periods presented, of Bioventus, LLC, the predecessor of Bioventus Inc. for financial reporting purposes.

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ended December 31, 2020 .

Triple-S Management Corporation (NYSE: GTS), a leading health services company in Puerto Rico, today announced that it has appointed Victor J. Haddock-Morales as Executive Vice President and Chief Financial Officer, effective May 10, 2021